Adjuvant treatment for early breast cancer
- 1 June 2005
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 16 (suppl_2) , ii182-ii187
- https://doi.org/10.1093/annonc/mdi709
Abstract
I. Smith; Breast cancer: Adjuvant treatment for early breast cancer, Annals of Oncology, Volume 16, Issue suppl_2, 1 June 2005, Pages ii182–ii187, https://doi.Keywords
This publication has 26 references indexed in Scilit:
- Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancerThe Lancet, 2005
- Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer DatabasesJournal of Clinical Oncology, 2003
- Incidence of Invasive Breast Cancer by Hormone Receptor Status From 1992 to 1998Journal of Clinical Oncology, 2003
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trialThe Lancet, 2002
- Findings From Recent National Surgical Adjuvant Breast and Bowel Project Adjuvant Studies in Stage I Breast CancerJNCI Monographs, 2001
- Scottish Adjuvant Tamoxifen Trial: a Randomized Study Updated to 15 YearsJNCI Journal of the National Cancer Institute, 2001
- UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 yearsPublished by Elsevier ,2000
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- The optimal duration of adjuvant tamoxifen treatment for breast cancer remains uncertain: Randomize into aTTomClinical Oncology, 1997
- Postchemotherapy Adjuvant Tamoxifen Therapy Beyond Five Years in Patients With Lymph Node-Positive Breast CancerJNCI Journal of the National Cancer Institute, 1996